arrow
E

Eduardo Forleo-Neto

university of colorado anschutz medical campus
H指数:20
被引数:1,977

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection
2024-11-060
PRE
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial

Garetosmab治疗进行性骨化性纤维发育不良: 一项随机、双盲、安慰剂对照2期试验

2023-09-2817
OAAI
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration
2023-06-1718
OAAI
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial
2023-04-191
OAAI
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial
2022-10-0125
OAAI
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19

Casirivimab和Imdevimab用于治疗住院新型冠状病毒肺炎患者

2022-07-2733
OAAI
COVID-19 prevention with subcutaneous administration of the monoclonal antibodies casirivimab and imdevimab: Subgroup analysis in participants with cardiovascular disease and diabetes
2021-12-011
OAAI
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19
2021-09-23242
OAAI
Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants
2020-09-0899
OAAI